Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eloxx Pharmaceuticals, Inc. | Director | Stock Options (Right to Buy) | 20K | Jun 15, 2022 | Direct | ||
Aura Biosciences, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 7, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AURA | Aura Biosciences, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
AURA | Aura Biosciences, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ELOX | Eloxx Pharmaceuticals, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
AURA | Aura Biosciences, Inc. | Oct 28, 2021 | 1 | $0 | 4 | Oct 29, 2021 | Director |
AURA | Aura Biosciences, Inc. | Oct 28, 2021 | 0 | $0 | 3 | Oct 28, 2021 | Director |
ELOX | Eloxx Pharmaceuticals, Inc. | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |
ELOX | Eloxx Pharmaceuticals, Inc. | May 13, 2021 | 2 | $3.33M | 4 | May 17, 2021 | Director |